Figure 4
Associations of prophylactic use of nafamostat with the incidence of PIP in (a) high-risk patients and (b) low-risk patients. RR risk ratio, CI confidence interval, PIP post-endoscopic retrograde cholangiopancreatography pancreatitis.
Figure 4 | Scientific Reports
